UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __1___)*
Accuhealth, Inc.
______________________________________________________
(Name of Issuer)
Common Stock, $ .01 Par Value
______________________________________________________
(Title of Class of Securities)
004380911
____________________________________
(CUSIP Number)
Austin W. Marxe, 153 East 53rd Street, New York, NY 10022
(212) 207-6500
______________________________________________________
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
December 31, 2000
_________________________________________________________
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of Rule 13d-
I(b)(3) or (4), check the following box ___.
Note: Six copies of this statement, including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of the cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to
the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D
CUSIP No. 004380911 Page 2 of 7 Pages
----------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Special Situations Fund III, L.P.
F13-3737427
MGP Advisers Limited Partnership *
F13-3263120
----------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) | |
(b) |X|
----------------------------------------------------------------
(3) SEC USE ONLY
----------------------------------------------------------------
(4) SOURCE OF FUNDS* 00
________________________________________________________________
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED
PURSUANT TO 2(d) OR 2(e) ____
_________________________________________________________________
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
----------------------------------------------------------------
NUMBER OF (7) SOLE VOTING POWER See Marxe/Greenhouse
SHARES -------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER None
OWNED BY -------------------------------------------------
EACH (9) SOLE DISPOSITIVE POWER See Marxe/Greenhouse
REPORTING ------------------------------------------------
PERSON WITH (10) SHARED DISPOSITIVE POWER None
----------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICALLY OWNED BY EACH REPORTING PERSON
589,479 (includes 425,000 cvt pfd)
----------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
----------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8
----------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IV/IA
----------------------------------------------------------------
* AWM Investment Company, Inc., a Delaware corporation is the
General Partner of this entity.
SCHEDULE 13D
CUSIP No. 004380911 Page 3 of 7 Pages
----------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Special Situations Cayman Fund, L.P.
98-0132442
AWM Investment Company, Inc.
11-3086452
----------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) | |
(b) |X|
----------------------------------------------------------------
(3) SEC USE ONLY
----------------------------------------------------------------
(4) SOURCE OF FUNDS* 00
________________________________________________________________
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED
PURSUANT TO 2(d) OR 2(e) ____
_________________________________________________________________
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
----------------------------------------------------------------
NUMBER OF (7) SOLE VOTING POWER See Marxe/Greenhouse
SHARES -------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER None
OWNED BY -------------------------------------------------
EACH (9) SOLE DISPOSITIVE POWER See Marxe/Greenhouse
REPORTING ------------------------------------------------
PERSON WITH (10) SHARED DISPOSITIVE POWER None
----------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICALLY OWNED BY EACH REPORTING PERSON
190,712 (includes 137,500 cvt pfd)
----------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
----------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.7
----------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IV/IA
----------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 004380911 Page 4 of 7 Pages
----------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Austin W. Marxe
David M. Greenhouse
----------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) | |
(b) |X|
----------------------------------------------------------------
(3) SEC USE ONLY
----------------------------------------------------------------
(4) SOURCE OF FUNDS* 00
________________________________________________________________
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED
PURSUANT TO 2(d) OR 2(e) ____
_________________________________________________________________
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
----------------------------------------------------------------
NUMBER OF (7) SOLE VOTING POWER 780,191
SHARES -------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER None
OWNED BY -------------------------------------------------
EACH (9) SOLE DISPOSITIVE POWER 780,191
REPORTING -------------------------------------------------
PERSON WITH (10) SHARED DISPOSITIVE POWER None
----------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICALLY OWNED BY EACH REPORTING PERSON
780,191 (includes 562,500 convertible preferred)
----------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
----------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.8
----------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
----------------------------------------------------------------
Page 5 of 7 Pages
Item 1. Security and Issuer. This statement (Schedule 13-D)
relates to the Common Stock, $ .01 Par Value of
Accuhealth, Inc.., a New York corporation (the
"Issuer"). The Issuer's principal executive office is
1575 Bronx River Avenue, Bronx, New York 10460.
Item 2. Identity and Background. This Schedule is filed on
behalf of (i) Special Situations Fund III, L.P., a
Delaware limited partnership ("SSF III"); (ii) Special
Situations Cayman Fund, L.P., a Cayman Islands limited
partnership (the "Cayman Fund"); (iii) MGP Advisers
Limited Partnership , a Delaware limited partnership
("MGP"); (iv) AWM Investment Company, Inc., a Delaware
corporation ("AWM"); (v) Austin W. Marxe and (vi) David
Greenhouse. Each of the foregoing is hereinafter
referred to, individually, as a "Reporting Person" and,
collectively, as the "Reporting Persons."
The principal office and business address of the
Reporting Persons, other than the Cayman Fund, is 153
East 53rd Street, 51st floor, New York, NY 10022. The
principal office and business address of the Cayman
Fund is c/o CIBC Bank and Trust Company (Cayman)
Limited, CIBC Bank Building, P. O. Box 694, Grand
Cayman, Cayman Islands, British West Indies.
The principal business of SSF III and the Cayman Fund
(individually, a "Fund" and, collectively, the "Funds")
is to invest in equity and equity related securities.
The principal business of MGP is to act as the general
partner of and the investment adviser to SSF III. The
principal business of AWM is to act as the general
partner of MGP and as the general partner of and the
investment adviser to the Cayman Fund. MGP and AWM are
referred to herein, individually, as an "Adviser" and,
collectively, as the "Advisers." The principal
occupation of Austin W. Marxe and David Greenhouse,
both of whom are United States citizens, is to serve as
officers, directors and members or principal
shareholders of the Advisers.
Neither any Fund, any Adviser, Austin W. Marxe nor
David Greenhouse, during the last 5 years, has been
convicted in any criminal proceeding or was or is
subject to a judgement, decree or final order enjoining
future violations of, or prohibiting or mandating
activities subject to, Federal or state securities laws
or finding any violations with respect to such laws.
Page 6 of 7 Pages
Item 3. Source and Amount of Funds or Other Consideration.
The business of the Fund is to acquire, purchase,
invest in, sell, convey, transfer, exchange and
otherwise trade in principally equity and equity
related securities. Each Fund utilized available cash
assets to purchase the Securities.
Item 4. Purpose of the Transaction. Each of the Reporting
Persons has acquired and is holding the Securities
solely for investment purposes and not with the purpose
or the effect of changing or influencing control of the
Issuer. Each Fund acquired the Securities in the
ordinary course of business and is holding such
Securities for the benefit of its third party
investors. The Fund has no plans or proposals in
respect of any of the matters set forth in the
instructions to this Item 4.
Item 5. Interest in Securities of the Issuer. See pps. 2-5 of
this Schedule, setting forth the aggregate number and
percentage of the Securities beneficially owned by each
Reporting Person, the number of shares as to which
there is sole or shared power to vote, or to direct the
vote, and sole or shared power to dispose or to direct
the disposition.
SSF III beneficially owns 425,000 shares of Cumulative
Convertible Preferred Stock convertible into 488,750
shares of Common Stock, and 100,729 shares of common
stock. Upon conversion of the preferred stock the fund
would own 10.8 % of the Issuers shares outstanding. CAY
beneficially owns 137,500 shares of Cumulative
Convertible Preferred Stock convertible into 158,125
shares of Common Stock and 32,587 shares of common
stock. Upon conversion of the preferred stock the CAY
would own 3.7 % of the Issuers shares outstanding.
In December 2000 SSF III and CAY sold 122,800 and
48,800 common shares respectively at an average price
of $.015 in open market trades.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer.
There are no contracts, arrangements, understandings or
relationships (legal or otherwise) between the
Fund and any other person with respect to any
securities of the Issuer. See Item 2 and Item 4 of
this Schedule. Based on such Items. Messrs. Marxe and
Greenhouse maintain sole voting power and sole
dispositive power with respect to the Securities.
Page 7 of 7 Pages
Item 7. Material to be Filed as Exhibits.
None
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
January 9, 2001
/s/ Austin W. Marxe
--------------------------------
Special Situations Fund III, L.P.
by: Austin W. Marxe, Managing Director
/s/ Austin W. Marxe
_____________________________
Special Situations Cayman Fund,L.P.
by: Austin Marxe, Managing Director
/s/ Austin W. Marxe
_____________________________
MGP Advisers Limited Partnership
by: Austin Marxe, President and CEO
/s/ Austin W. Marxe
_____________________________
AWM Investment Company, Inc.
by: Austin Marxe, President and CEO
/s/ Austin W. Marxe
_____________________________
Austin W. Marxe
/s/ David Greenhouse
_____________________________
David Greenhouse
